Bayer AG raised its annual profit outlook after increased demand for some of its newer drugs drove a better-than-expected performance at its pharmaceutical unit. Source: Bloomberg Markets · Summarized by HeadlinesBriefing Related articlesSpain inflict Wiegman's heaviest England defeat as World Cup play-offs loomAT&T Lifts Profit Outlook on Continued Postpaid Phone, Internet GrowthBotched final play sees Luka hesitate, LeBron miss3M Lifts Earnings Outlook as Profit JumpsEngland booed off after limp Japan defeatMore from Bloomberg MarketsBOE Interest-Rate Path Divides Traders and Economists Ahead of Expected HikeJefferies CEO Visits India as US Firm Eyes Expansion, HiringCongo to Probe Illegal Mining After Seizing Copper and CobaltBrookfield, Lunate Set Up New Gulf Property Development FirmTurkish Stock Market Chief Arrested in Funds Probe, Anadolu SaysLatest in Public MarketsU.S. Treasury Yields Rise as Markets Await Midterm Election Results · Wall Street Journal MarketsGrab Pivots Back to Southeast Asia After Blocked Taiwan Deal · Wall Street Journal US BusinessSaudi Aramco Profit Surges, Offering Some Relief to Kingdom’s Finances · Wall Street Journal US BusinessSaudi Aramco Profit Jumps Despite Damaging Attacks on Pipelines and Refineries · New York Times Top StoriesBayer Raises Earnings Outlook on Pharma Recovery · Wall Street Journal US BusinessRelated briefingsMarkets 24-Hour BriefingMarkets 8-Hour BriefingHomePublic MarketsBayer Raises Profit Outlook on Strong Demand for DrugsSectionsHomePublic MarketsPrivate MarketsTech & GamesMobileDeveloperF1Sports